Last updated 2026-07-27
- Went public on TSX Venture Exchange (ZCT), Nov 2024
- Public offering on OTCQB Venture Market, Mar 2025
- Public offering on Frankfurt Stock Exchange, Jan 2025
Total raised
$2.9M
Stage
Public
Founded
2022
Headcount
20
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Zero Candida Technologies is an Israeli FemTech medical device company focused on revolutionizing women's health. The company is developing an AI-driven smart tampon-like device that utilizes therapeutic blue light at a precise wavelength and intensity to effectively treat Candida fungus, with a proven 99.999% success rate in proof-of-concept studies. The device aims to provide a non-drug, side-effect-free solution for Vulvo-Vaginal Candidiasis (VVC), a condition affecting a significant portion of women worldwide. Zero Candida is also working on technology to provide hybrid gynecological medical services to underserved communities globally, enabling remote diagnosis and personalized treatment through real-time data transmission.
Funding history · 5 rounds · $2.9M total
2025
SPAC
Undisclosed
conduit+reconcile
★ Undisclosed
2024-11
Reverse Merger
$2.9M
conduit+reconcile
2024-11
Public Offering
Undisclosed
conduit+reconcile
2024
SPAC
$4.0M
conduit+reconcile
2023-03
Crowdfunding
Undisclosed
conduit+reconcile
★ Undisclosed
Q&A
- What is Zero Candida Technologies' primary focus?
- Zero Candida Technologies is an Israeli FemTech medical device company developing an AI-driven smart tampon-like device for the non-drug treatment of vaginal candidiasis using therapeutic blue light.
- What is the status of Zero Candida Technologies' ZC-001 therapeutic device?
- In October 2025, Zero Candida achieved design freeze and began prototype production of its ZC-001 therapeutic device. By February 2026, the company scaled production to 250 ISO 13485 clinical-grade prototypes.
- Has Zero Candida Technologies been granted any patents recently?
- Yes, in June 2026, Zero Candida Technologies announced it was officially granted Patent No. 12654025B2.
- Who are the co-founders of Zero Candida Technologies?
- Eli Ben Haroosh, who also serves as CEO, and Asher Holzer are the co-founders of Zero Candida Technologies.
- What is the employee count for Zero Candida Technologies?
- Zero Candida Technologies has an employee count in the 11-50 range.
- When was Zero Candida Technologies founded?
- Zero Candida Technologies was founded in January 2022.
Team · 1
Eli Ben Haroosh
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
ConsumersDemographics & FamilyWomen
Business model
B2B
Tags
femtechgynecology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | zero-candida.com |
|---|---|
| linkedin.com/company/105038442 | |
| X / Twitter | ZeroCandida |
| facebook.com/ZeroCandida/ |
Identifiers & details
| Legal name | ZERO CANDIDA LTD |
|---|---|
| Founded | 2022-1 |
| Employees (exact) | 20 |
| Offices | Vancouver |
| Status reason | Public on TSXV on Nov 2024; |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2024-11 | TSX Venture Exchange | ZCT | |
| Listing | 2025-01 | Frankfurt Stock Exchange | 9L2 | |
| Listing | 2025-03 | OTCQB Venture Market | ZCTFF |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516520657 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-01-03 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הפלך 7 תל אביב - יפו |